Aligos Therapeutics, Inc. (ALGS) Balance sheet

Market cap

$5.51M

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	221	187	81	136	37
Marketable securities, current	23	4	44	-	20
Total cash & short-term investments	244	191	126	136	57
Total current assets	250	204	134	141	62
Property, plant and equipment, net	8	6	5	3	2
Marketable securities, non-current	-	15	-	-	-
Total non-current assets	15	31	13	10	8
Total assets	265	235	147	152	70
Accounts payable	3	3	5	3	3
Total current liabilities	30	39	33	24	22
Total non-current liabilities	15	12	10	36	77
Total liabilities	45	51	43	59	99
Common stock and paid-in capital	0	0	0	0	0
Retained earnings	-175	-303	-399	-487	-618
Stockholders' equity	220	185	104	92	-29